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Vascular Cell is launching new series on lymphatics, a vascular system required for physiological fluid balance and
immunity, and whose damage leads to edema.Editorial
It has been over a century since the mammalian lymphatic
system was first described in precise anatomical graphical
presentations [1]. Since that time, we have seen dramatic
advances in our description of lymphatics. We can now
read numerous published reports that provide fascinating
details of the molecular, cellular, and functional aspects
of lymphatics. Lymphatic researchers have achieved a mo-
lecular precision by which they can now describe lymph-
atic development, function, and lymphatic diseases.
Vascular Cell announces the launch of a thematic series
on “Lymphatics in health and disease”. This series comes
at a time when the field has matured and is ripe for trans-
lation into treatments for lymphatic disorders. This the-
matic series will provide reviews from experts on the
study of the biology of lymphatic vasculature and on the
role of lymphatic vessels in disease states such as edema,
inflammatory diseases, and cancer.
The lymphatic vascular system functions to return tissue
fluid, macromolecules, and cells back to the blood circula-
tion. During mammalian embryogenesis, formation of the
lymphatic vascular system is an early and essential
process. Lymphatics develop by sprouting from the lymph
sacs, which originate from the embryonic veins, thus
lymphatic development follows arterial-venous specifica-
tion. Lymphangiogenesis proceeds in parallel with angio-
genesis, generating tissues rich in both blood and
lymphatic vessels.
Disruption of the lymphatic system can occur due to
inherited mutations in affected individuals or secondarily
as a result of surgery. When lymphatics do not form or* Correspondence: jkk9@columbia.edu
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reproduction in any medium, provided the orfunction properly, drainage of interstitial fluids is reduced
and fluid accumulates, causing what is referred to as
lymphedema. The causes of lymphedema can include
an insufficient number of lymphatic vessels, reduced
lymphangiogenesis, impaired function of lymphatic valves,
loss of vascular smooth muscle cells, or obstruction of
lymphatic vessels. Reduced lymphatic function ultimately
leads to accumulation of the protein-rich lymph fluid with
contains proteins, imflammatory cells and lipids. The gen-
etic basis of some congenital hereditary lymphedemas is
known and is often associated with mutations in gene re-
gion encoding the tyrosine kinase domain of VEGFR-3.
During tumor growth, lymphatics can be recruited to
extra- or intra-tumoral sites and contribute to the path-
ology by serving as a conduit for metastatic cells.
A variety of topics will be covered in this thematic series,
a list of which could derive from session topics of a recent
meeting on lymphatics sponsored by Yale University and
the North American Vascular Biology Organization or
NAVBO (see www.navbo.org/lymphatics) or an upcoming
2014 Gordon Conference entitled Molecular Mechanisms
in Lymphatic Function & Disease: State-of-the-Art in
Lymphatic Research and Biology. We invite reviews that
cover the growth factors, receptors, effectors and tran-
scriptional regulators that drive the specification and for-
mation of the lymphatics during development and in adult
tissues [2]. Descriptions are needed on how lymphatics
function to promote fluid and lipid absorption, maintain
directional flow and participate in immune surveillance. A
discussion of lymphatic dysfunction due to genetic defi-
ciencies or surgery-induced damage should be considered
in order to better chart the path toward repair [3]. One
must also consider that tumors can recruit lymphatics,
tumor cells can enter the lymphatic system and spread to
lymph nodes [4]; events critical to both diagnosis andral Ltd. This is an Open Access article distributed under the terms of the Creative
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tional aspects of lymphatic circulation such as an emergent
area of blood pressure control [5] can be considered.
To submit your manuscript, please use the online
submission system for Vascular Cell and indicate in
your cover letter that you would like it to be considered
for the thematic series on lymphatics. Alternately,
please send a pre-submission enquiry to either Jan
Kitajewski at jkk9@columbia.edu, Carrie Shawber at
cjs2002@columbia.edu, or Michael Simons at michael.
simons@yale.edu. Go with the flow and contribute to
this thematic series on the amazing lymphatic vascular
system.
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